FDA.reportPublic FDA data

ofloxacin Ophthalmic Product

RxCUI
1160451
RxNorm name
ofloxacin Ophthalmic Product
Term type
SCDG
Status
Active
Updated
2026-10-15 15:42:46

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102011
Active start
102011
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ofloxacin7623

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRofloxacin Ophthalmic Product1NAMES
RxNorm Nameofloxacin Ophthalmic Product1NAMES
TTYSCDG1ATTRIBUTES
RxCUI11604511CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS02AAAntiinfectivesATC1-4ofloxacin
ATCS01AEFluoroquinolonesATC1-4ofloxacin
ATCJ01MAFluoroquinolonesATC1-4ofloxacin
FDASPLD015363QuinolonesCHEMhas_chemical_structureofloxacin
FDASPLN0000175937Quinolone AntimicrobialEPChas_epcofloxacin
MEDRTD015242OfloxacinCHEMhas_ingredientofloxacin
MEDRTD001991BronchitisDISEASEmay_treatofloxacin
MEDRTD002690Chlamydia InfectionsDISEASEmay_treatofloxacin
MEDRTD003234Conjunctivitis, BacterialDISEASEmay_treatofloxacin
MEDRTD003320Corneal UlcerDISEASEmay_treatofloxacin
MEDRTD003556CystitisDISEASEmay_treatofloxacin
MEDRTD004342Drug HypersensitivityDISEASEci_withofloxacin
MEDRTD004823EpididymitisDISEASEmay_treatofloxacin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatofloxacin
MEDRTD006069GonorrheaDISEASEmay_treatofloxacin
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatofloxacin
MEDRTD016481Helicobacter InfectionsDISEASEmay_treatofloxacin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatofloxacin
MEDRTD010032Otitis ExternaDISEASEmay_treatofloxacin
MEDRTD010035Otitis Media, SuppurativeDISEASEmay_treatofloxacin
MEDRTD011472ProstatitisDISEASEmay_treatofloxacin
MEDRTD011512Proteus InfectionsDISEASEmay_treatofloxacin
MEDRTD012480Salmonella InfectionsDISEASEmay_treatofloxacin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatofloxacin
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatofloxacin
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatofloxacin
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatofloxacin
MEDRTD014552Urinary Tract InfectionsDISEASEmay_treatofloxacin
MEDRTN0000020086DNA Gyrase InhibitorsMOAhas_moaofloxacin
MEDRTN0000020087Topoisomerase 4 InhibitorsMOAhas_moaofloxacin
MEDRTN0000008576Decreased DNA IntegrityPEhas_peofloxacin
MEDRTN0000008577Decreased DNA ReplicationPEhas_peofloxacin
MEDRTN0000009011Decreased Transcription to RNAPEhas_peofloxacin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH3 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESSNOMEDCT392419009
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceUS Edition of SNOMED_CT